Amdocs Reports Q3 2024 Financial Results

Ticker: DOX · Form: 6-K · Filed: Aug 8, 2024 · CIK: 1062579

Amdocs LTD 6-K Filing Summary
FieldDetail
CompanyAmdocs LTD (DOX)
Form Type6-K
Filed DateAug 8, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: earnings, financial-results, disclosure

TL;DR

Amdocs dropped its Q3 2024 earnings report on Aug 7th. Check the exhibits for the deets.

AI Summary

Amdocs Limited announced its financial results for the quarter ended June 30, 2024, on August 7, 2024. The company issued a press release and accompanying presentation detailing these results, which are furnished as exhibits to this Form 6-K filing.

Why It Matters

This filing provides investors with the latest financial performance data for Amdocs, enabling them to assess the company's profitability and operational health.

Risk Assessment

Risk Level: low — This is a routine financial results disclosure, not indicating any unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to report Amdocs Limited's financial results for the quarter ended June 30, 2024, through a press release and accompanying presentation furnished as exhibits.

When did Amdocs announce its financial results for the quarter ended June 30, 2024?

Amdocs announced its financial results for the quarter ended June 30, 2024, on August 7, 2024.

What exhibits are included with this Form 6-K?

This Form 6-K includes Exhibits 99.1 (the press release) and 99.2 (the accompanying presentation) detailing the financial results.

What is Amdocs Limited's fiscal year end?

Amdocs Limited's fiscal year end is September 30.

Under which SEC Act is this report filed?

This report is filed under the Securities Exchange Act of 1934, pursuant to Rule 13a-16 or 15d-16.

Filing Stats: 276 words · 1 min read · ~1 pages · Grade level 9.4 · Accepted 2024-08-07 21:34:57

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AMDOCS LIMITED By: /s/ Matthew E. Smith Matthew E. Smith Secretary and Authorized Signatory Date: August 7, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing